352 related articles for article (PubMed ID: 18690918)
1. Role of vitamin K2 in the treatment of postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Drug Saf; 2006 Jan; 1(1):87-97. PubMed ID: 18690918
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with vitamin k2 and bisphosphonate in postmenopausal women with osteoporosis.
Iwamoto J; Takeda T; Ichimura S
Yonsei Med J; 2003 Oct; 44(5):751-6. PubMed ID: 14584089
[TBL] [Abstract][Full Text] [Related]
3. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW
Osteoporos Int; 2015 Mar; 26(3):1175-86. PubMed ID: 25516361
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
[TBL] [Abstract][Full Text] [Related]
5. Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis.
Kasukawa Y; Miyakoshi N; Ebina T; Aizawa T; Hongo M; Nozaka K; Ishikawa Y; Saito H; Chida S; Shimada Y
J Bone Miner Metab; 2014 May; 32(3):290-7. PubMed ID: 23846118
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K to prevent fractures in older women: systematic review and economic evaluation.
Stevenson M; Lloyd-Jones M; Papaioannou D
Health Technol Assess; 2009 Sep; 13(45):iii-xi, 1-134. PubMed ID: 19818211
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
8. Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Nutr Rev; 2006 Dec; 64(12):509-17. PubMed ID: 17274493
[TBL] [Abstract][Full Text] [Related]
9. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
10. Comparison of concurrent treatment with vitamin K
Tanaka S; Miyazaki T; Uemura Y; Miyakawa N; Gorai I; Nakamura T; Fukunaga M; Ohashi Y; Ohta H; Mori S; Hagino H; Hosoi T; Sugimoto T; Itoi E; Orimo H; Shiraki M
J Bone Miner Metab; 2017 Jul; 35(4):385-395. PubMed ID: 27484436
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment of vertebral osteoporosis.
Lippuner K
Eur Spine J; 2003 Oct; 12 Suppl 2(Suppl 2):S132-41. PubMed ID: 13680313
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
[TBL] [Abstract][Full Text] [Related]
13. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of antiresorptive agents for preventing fractures in Japanese patients with an increased fracture risk: review of the literature.
Iwamoto J; Sato Y; Takeda T; Matsumoto H
Drugs Aging; 2012 Mar; 29(3):191-203. PubMed ID: 22372723
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
Zhou J; Ma X; Wang T; Zhai S
Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112
[TBL] [Abstract][Full Text] [Related]
16. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
17. [Update on treatment of postmenopausal osteoporosis].
Body JJ
Rev Med Brux; 2008 Sep; 29(4):301-9. PubMed ID: 18949981
[TBL] [Abstract][Full Text] [Related]
18. Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).
Tanaka S; Miyazaki T; Uemura Y; Kuroda T; Miyakawa N; Nakamura T; Fukunaga M; Ohashi Y; Ohta H; Mori S; Hagino H; Hosoi T; Sugimoto T; Itoi E; Orimo H; Shiraki M
J Bone Miner Metab; 2014 May; 32(3):298-304. PubMed ID: 23828145
[TBL] [Abstract][Full Text] [Related]
19. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
Iwamoto J
Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
[TBL] [Abstract][Full Text] [Related]
20. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Ichimura S
Keio J Med; 2003 Sep; 52(3):147-50. PubMed ID: 14529146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
